Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.

Saved in:
Bibliographic Details
Title: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Authors: Khera N; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Edwards ML; Analysis Group Inc., New York, NY, USA., Song Y; Analysis Group Inc., Boston, MA, USA., Sun R; Analysis Group Inc., Boston, MA, USA., Manghani R; Gamida Cell Inc., Boston, MA, USA., Shin H; Gamida Cell Inc., Boston, MA, USA., Simantov R; Gamida Cell Inc., Boston, MA, USA., Signorovitch J; Analysis Group Inc., Boston, MA, USA., Sivaraman S; Gamida Cell Inc., Boston, MA, USA., Gergis U; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu.
Source: Advances in therapy [Adv Ther] 2024 Apr; Vol. 41 (4), pp. 1637-1651. Date of Electronic Publication: 2024 Mar 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38427220
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Khera+N%22">Khera N</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+ML%22">Edwards ML</searchLink>; Analysis Group Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+R%22">Sun R</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Manghani+R%22">Manghani R</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shin+H%22">Shin H</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Simantov+R%22">Simantov R</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Signorovitch+J%22">Signorovitch J</searchLink>; Analysis Group Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sivaraman+S%22">Sivaraman S</searchLink>; Gamida Cell Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gergis+U%22">Gergis U</searchLink>; Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Ste 308, Philadelphia, PA, 19107, USA. usama.gergis@jefferson.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2024 Apr; Vol. 41 (4), pp. 1637-1651. <i>Date of Electronic Publication: </i>2024 Mar 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38427220
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-023-02771-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1637
    Titles:
      – TitleFull: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Khera N
      – PersonEntity:
          Name:
            NameFull: Edwards ML
      – PersonEntity:
          Name:
            NameFull: Song Y
      – PersonEntity:
          Name:
            NameFull: Sun R
      – PersonEntity:
          Name:
            NameFull: Manghani R
      – PersonEntity:
          Name:
            NameFull: Shin H
      – PersonEntity:
          Name:
            NameFull: Simantov R
      – PersonEntity:
          Name:
            NameFull: Signorovitch J
      – PersonEntity:
          Name:
            NameFull: Sivaraman S
      – PersonEntity:
          Name:
            NameFull: Gergis U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1